Add Yahoo as a preferred source to see more of our stories on Google. On August 7, the U.S. Food and Drug Administration (FDA) approved the nalmefene hydrochloride auto-injector that is used in the ...

Innovative product development firm Cambridge Consultants has developed a new auto-injector to deliver viscous progesterone in oil (PiO) hormonal injections in women undergoing in vitro fertilisation ...

Anaphylaxis is a serious, potentially life-threatening allergic reaction that can affect several organ systems in the body and may threaten breathing and blood circulation. The most common causes of ...

Impax Labs issued an update on its Epinephrine Injection, USP Auto-Injector 0.15mg and 0.3mg, the generic of Adrenaclick, indicating the product is currently available. Impax Labs issued an update on ...

Naloxone Auto-Injector is specifically designed to be a medical countermeasure for military personnel or chemical incident responders against the potential threat of exposure to synthetic opioids on ...

Stevanato has added another drug delivery technology to its portfolio, teaming up with Owen Mumford to provide customers with a two-step, single-use auto-injector that automatically adapts to a range ...

People use epinephrine injections as a medication to treat severe allergic reactions. Epinephrine, also called adrenaline, is a hormone that the adrenal glands produce in the body. People who have ...

The two companies signed an exclusive collaboration agreement for the Aidaptus auto-injector. Owen Mumford, a medical device manufacturer, announced on May 4, 2022 that it has signed an exclusive ...

The first nalmefene hydrochloride (HCl) auto-injector (Zurnai) brings a new tool to the fight against the opioid overdose epidemic but is not without controversy. As reported earlier this month, the ...

The auto injector market represents a rapidly expanding segment within the global pharmaceutical delivery systems industry, driven by the increasing prevalence of chronic diseases and the growing ...

The US Food and Drug Administration (FDA) has approved the first nalmefene hydrochloride auto-injector (Zurnai; Purdue Pharma LP) for the treatment of known or suspected opioid overdose in people aged ...